San Francisco Bay Area-based Tethys Bioscience has received another round of cash on the order of tens of millions, putting their total funding to date at $54 million, says a Wired article. Their test will use protein biomarkers to determine whether someone will become diabetic way before standard diagnostic tests reveal the condition. Instead of relying on genetic markers, Tethys says "using biomarkers like proteins in the blood might provide an even better way than examining genes to answer a patient's most pressing question: Will I get sick?," says the article.
Predictive Protein Test Sounds Better Than Personal Genome Service Anyway
Jan 11, 2008